Histogenics closed its previously-announced US $30.0MM private placement. Funds will support development of NeoCart® novel cartilage repair therapy, including completion of the ongoing Phase III clinical trial.
icotec launched the brand name of BlackArmor® for its Carbon/PEEK material, which has been used in spinal and fracture repair devices for 15 years in 20,000 implantations.Â
AxioMed received approval from the Therapeutic Goods Administration to market cervical and lumbar Freedom Viscoelastic Disc Replacement devices in Australia.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more